|
1
|
Alzheimer's Association: 2013 Alzheimer's
disease facts and figures. Alzheimers Dement. 9:208–245. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Golebiowski M, Barcikowska M and Pfeffer
A: Magnetic resonance imaging-based hippocampal volumetry in
patients with dementia of the Alzheimer type. Dement Geriatr Cogn
Disord. 10:284–288. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Heun R, Mazanek M, Atzor KR, Tintera J,
Gawehn J, Burkart M, Gänsicke M, Falkai P and Stoeter P:
Amygdala-hippocampal atrophy and memory performance in dementia of
Alzheimer type. Dement Geriatr Cogn Disord. 8:329–336. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fox NC, Warrington EK, Freeborough PA,
Hartikainen P, Kennedy AM, Stevens JM and Rossor MN: Presymptomatic
hippocampal atrophy in Alzheimer's disease. A longitudinal MRI
study. Brain. 119:2001–2007. 1996. View Article : Google Scholar
|
|
5
|
Querfurth HW and LaFerla FM: Alzheimer's
disease. N Engl J Med. 362:329–344. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
D'Aniello A, Fisher G, Migliaccio N,
Cammisa G, D'Aniello E and Spinelli P: Amino acids and
transaminases activity in ventricular CSF and in brain of normal
and Alzheimer patients. Neurosci Lett. 388:49–53. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Selkoe DJ: Alzheimer's disease results
from the cerebral accumulation and cytotoxicity of amyloid
beta-protein. J Alzheimers Dis. 3:75–80. 2001.
|
|
8
|
Culmsee C and Landshamer S: Molecular
insights into mechanisms of the cell death program: Role in the
progression of neurodegenerative disorders. Curr Alzheimer Res.
3:269–283. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Honda K, Casadesus G, Petersen RB, Perry G
and Smith MA: Oxidative stress and redox-active iron in Alzheimer's
disease. Ann N Y Acad Sci. 1012:179–182. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jenner P: Oxidative stress in Parkinson's
disease. Ann Neurol. 53(Suppl 3): S26–S36; discussion S36–S38.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Su JH, Anderson AJ, Cummings BJ and Cotman
CW: Immunohistochemical evidence for apoptosis in Alzheimer's
disease. Neuroreport. 5:2529–2533. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yagami T, Ueda K, Asakura K, Sakaeda T,
Nakazato H, Kuroda T, Hata S, Sakaguchi G, Itoh N, Nakano T, et al:
Gas6 rescues cortical neurons from amyloid beta protein-induced
apoptosis. Neuropharmacology. 43:1289–1296. 2002. View Article : Google Scholar
|
|
13
|
Wang DM, Li SQ, Zhu XY, Wang Y, Wu WL and
Zhang XJ: Protective effects of hesperidin against amyloid-β (Aβ)
induced neurotoxicity through the voltage dependent anion channel 1
(VDAC1)-mediated mitochondrial apoptotic pathway in PC12 cells.
Neurochem Res. 38:1034–1044. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schenk D, Barbour R, Dunn W, Gordon G,
Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, et al:
Immunization with amyloid-beta attenuates Alzheimer-disease-like
pathology in the PDAPP mouse. Nature. 400:173–177. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shao BY, Xia Z, Xie Q, Ge XX, Zhang WW,
Sun J, Jiang P, Wang H, Le WD, Qiu ZB, et al: Meserine, a novel
carbamate AChE inhibitor, ameliorates scopolamine-induced dementia
and alleviates amyloidogenesis of APP/PS1 transgenic mice. CNS
Neurosci Ther. 20:165–171. 2014. View Article : Google Scholar
|
|
16
|
Liu MY, Wang S, Yao WF, Zhang ZJ, Zhong X,
Sha L, He M, Zheng ZH and Wei MJ: Memantine improves spatial
learning and memory impairments by regulating NGF signaling in
APP/PS1 transgenic mice. Neuroscience. 273:141–151. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sadowski M and Wisniewski T: Disease
modifying approaches for Alzheimer's pathology. Curr Pharm Des.
13:1943–1954. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ritch PS, Carroll SL and Sontheimer H:
Neuregulin-1 enhances survival of human astrocytic glioma cells.
Glia. 51:217–228. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mei L and Xiong WC: Neuregulin 1 in neural
development, synaptic plasticity and schizophrenia. Nat Rev
Neurosci. 9:437–452. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao WJ and Schachner M: Neuregulin 1
enhances cell adhesion molecule l1 expression in human glioma cells
and promotes their migration as a function of malignancy. J
Neuropathol Exp Neurol. 72:244–255. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao WJ: The expression and localization
of neuregulin-1 (Nrg1) in the gastrointestinal system of the rhesus
monkey. Folia Histochem Cytobiol. 51:38–44. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao W and Ren SG: Neuregulin-1 (Nrg1) is
mainly expressed in rat pituitary gonadotroph cells and possibly
regulates prolactin (PRL) secretion in a juxtacrine manner. J
Neuroendocrinol. 23:1252–1262. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao W, Shen Y and Ren S: Endogenous
expression of Neuregulin-1 (Nrg1) as a potential modulator of
prolactin (PRL) secretion in GH3 cells. Cell Tissue Res.
344:313–320. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao WJ, Jiang Q and Mei JP:
Neurohypophyseal Neuregulin 1 is derived from the hypothalamus as a
potential prolactin modulator. Neuroendocrinology. 102:288–299.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wilson TR, Lee DY, Berry L, Shames DS and
Settleman J: Neuregulin-1-mediated autocrine signaling underlies
sensitivity to HER2 kinase inhibitors in a subset of human cancers.
Cancer Cell. 20:158–172. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao WJ and Ren SG: Endogenous
neuregulin-1 expression in the anterior pituitary of female
Wistar-Furth rats during the estrous cycle. Nan Fang Yi Ke Da Xue
Xue Bao. 31:921–927. 2011.In Chinese. PubMed/NCBI
|
|
27
|
Liu J and Kern JA: Neuregulin-1 activates
the JAK-STAT pathway and regulates lung epithelial cell
proliferation. Am J Respir Cell Mol Biol. 27:306–313. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Puricelli L, Proietti CJ, Labriola L,
Salatino M, Balañá ME, Aguirre Ghiso J, Lupu R, Pignataro OP,
Charreau EH, Bal de Kier Joffé E and Elizalde PV: Heregulin
inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase
activation but regulates urokinase plasminogen activator
independently of these pathways in metastatic mammary tumor cells.
Int J Cancer. 100:642–653. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Falls DL: Neuregulins: Functions, forms,
and signaling strategies. Exp Cell Res. 284:14–30. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Stefansson H, Sigurdsson E,
Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S,
Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, et al:
Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet.
71:877–892. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Britsch S: The neuregulin-I/ErbB signaling
system in development and disease. Adv Anat Embryol Cell Biol.
190:1–65. 2007.PubMed/NCBI
|
|
32
|
Xu Z, Croslan DR, Harris AE, Ford GD and
Ford BD: Extended therapeutic window and functional recovery after
intraarterial administration of neuregulin-1 after focal ischemic
stroke. J Cereb Blood Flow Metab. 26:527–535. 2006. View Article : Google Scholar
|
|
33
|
Carlsson T, Schindler FR, Höllerhage M,
Depboylu C, Arias-Carrión O, Schnurrbusch S, Rösler TW, Wozny W,
Schwall GP, Groebe K, et al: Systemic administration of
neuregulin-1β1 protects dopaminergic neurons in a mouse model of
Parkinson's disease. J Neurochem. 117:1066–1074. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tokita Y, Keino H, Matsui F, Aono S,
Ishiguro H, Higashiyama S and Oohira A: Regulation of neuregulin
expression in the injured rat brain and cultured astrocytes. J
Neurosci. 21:1257–1264. 2001.PubMed/NCBI
|
|
35
|
Chaudhury AR, Gerecke KM, Wyss JM, Morgan
DG, Gordon MN and Carroll SL: Neuregulin-1 and erbB4
immunoreactivity is associated with neuritic plaques in Alzheimer
disease brain and in a transgenic model of Alzheimer disease. J
Neuropathol Exp Neurol. 62:42–54. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yarden Y and Sliwkowski MX: Untangling the
ErbB signalling network. Nat Rev Mol Cell Biol. 2:127–137. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mei L and Nave KA: Neuregulin-ERBB
signaling in the nervous system and neuropsychiatric diseases.
Neuron. 83:27–49. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kanzaki H, Mizobuchi S, Obata N, Itano Y,
Kaku R, Tomotsuka N, Nakajima H, Ouchida M, Nakatsuka H, Maeshima K
and Morita K: Expression changes of the neuregulin 1 isoforms in
neuropathic pain model rats. Neurosci Lett. 508:78–83. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Maiese K, Li F and Chong ZZ:
Erythropoietin in the brain: Can the promise to protect be
fulfilled? Trends Pharmacol Sci. 25:577–583. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mattson MP: Pathways towards and away from
Alzheimer's disease. Nature. 430:631–639. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chong ZZ, Li F and Maiese K: Oxidative
stress in the brain: Novel cellular targets that govern survival
during neurodegenerative disease. Prog Neurobiol. 75:207–246. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Mattson MP: Oxidative stress, perturbed
calcium homeostasis, and immune dysfunction in Alzheimer's disease.
J Neurovirol. 8:539–550. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Facecchia K, Fochesato LA, Ray SD, Stohs
SJ and Pandey S: Oxidative toxicity in neurodegenerative diseases:
Role of mitochondrial dysfunction and therapeutic strategies. J
Toxicol. 2011:6837282011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Viegas CM, Tonin AM, Zanatta A, Seminotti
B, Busanello EN, Fernandes CG, Moura AP, Leipnitz G and Wajner M:
Impairment of brain redox homeostasis caused by the major
metabolites accumulating in
hyperornithinemia-hyperammonemia-homocitrullinuria syndrome in
vivo. Metab Brain Dis. 27:521–530. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Herbert V, Shaw S, Jayatilleke E and
Stopler-Kasdan T: Most free-radical injury is iron-related: It is
promoted by iron, hemin, holoferritin and vitamin C, and inhibited
by desferoxamine and apoferritin. Stem Cells. 12:289–303. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Guo WP, Fu XG, Jiang SM and Wu JZ:
Neuregulin-1 regulates the expression of Akt, Bcl-2, and Bad
signaling after focal cerebral ischemia in rats. Biochem Cell Biol.
88:649–654. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Calvo M, Zhu N, Tsantoulas C, Ma Z, Grist
J, Loeb JA and Bennett DL: Neuregulin-ErbB signaling promotes
microglial proliferation and chemotaxis contributing to
microgliosis and pain after peripheral nerve injury. J Neurosci.
30:5437–5450. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Erlich S, Goldshmit Y, Lupowitz Z and
Pinkas-Kramarski R: ErbB-4 activation inhibits apoptosis in PC12
cells. Neuroscience. 107:353–362. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Dimayuga FO, Ding Q, Keller JN, Marchionni
MA, Seroogy KB and Bruce-Keller AJ: The neuregulin GGF2 attenuates
free radical release from activated microglial cells. J
Neuroimmunol. 136:67–74. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cui W, Tao J, Wang Z, Ren M, Zhang Y, Sun
Y, Peng Y and Li R: Neuregulin1beta1 antagonizes apoptosis via
ErbB4-dependent activation of PI3-kinase/Akt in APP/PS1 transgenic
mice. Neurochem Res. 38:2237–2246. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yu W, Bonnet M, Farso M, Ma K, Chabot JG,
Martin E, Torriglia A, Guan Z, McLaurin J, Quirion R and Krantic S:
The expression of apoptosis inducing factor (AIF) is associated
with aging-related cell death in the cortex but not in the
hippocampus in the TgCRND8 mouse model of Alzheimer's disease. BMC
Neurosci. 15:732014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Cecchi C, Fiorillo C, Baglioni S,
Pensalfini A, Bagnoli S, Nacmias B, Sorbi S, Nosi D, Relini A and
Liguri G: Increased susceptibility to amyloid toxicity in familial
Alzheimer's fibroblasts. Neurobiol Aging. 28:863–876. 2007.
View Article : Google Scholar
|
|
53
|
Miranda S, Opazo C, Larrondo LF, Muñoz FJ,
Ruiz F, Leighton F and Inestrosa NC: The role of oxidative stress
in the toxicity induced by amyloid beta-peptide in Alzheimer's
disease. Prog Neurobiol. 62:633–648. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Hardy JA and Higgins GA: Alzheimer's
disease: The amyloid cascade hypothesis. Science. 256:184–185.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Karran E, Mercken M and De Strooper B: The
amyloid cascade hypothesis for Alzheimer's disease: An appraisal
for the development of therapeutics. Nat Rev Drug Discov.
10:698–712. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Thangnipon W, Puangmalai N,
Chinchalongporn V, Jantrachotechatchawan C, Kitiyanant N,
Soi-Ampornkul R, Tuchinda P and Nobsathian S: N-benzylcinnamide
protects rat cultured cortical neurons from β-amyloid
peptide-induced neurotoxicity. Neurosci Lett. 556:20–25. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Chen TJ, Wang DC and Chen SS: Amyloid-beta
interrupts the PI3K-Akt-mTOR signaling pathway that could be
involved in brain-derived neurotrophic factor-induced Arc
expression in rat cortical neurons. J Neurosci Res. 87:2297–2307.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Tong L, Balazs R, Thornton PL and Cotman
CW: Beta-amyloid peptide at sublethal concentrations downregulates
brain-derived neurotrophic factor functions in cultured cortical
neurons. J Neurosci. 24:6799–6809. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Parkinson DB, Langner K, Namini SS, Jessen
KR and Mirsky R: beta-Neuregulin and autocrine mediated survival of
Schwann cells requires activity of Ets family transcription
factors. Mol Cell Neurosci. 20:154–167. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Xu Z, Jiang J, Ford G and Ford BD:
Neuregulin-1 is neuroprotective and attenuates inflammatory
responses induced by ischemic stroke. Biochem Biophys Res Commun.
322:440–446. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Xu Z, Ford GD, Croslan DR, Jiang J, Gates
A, Allen R and Ford BD: Neuroprotection by neuregulin-1 following
focal stroke is associated with the attenuation of ischemia-induced
pro-inflammatory and stress gene expression. Neurobiol Dis.
19:461–470. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Liu Y, Yu Y, Schachner M and Zhao W:
Neuregulin 1-β regulates cell adhesion molecule L1 expression in
the cortex and hippocampus of mice. Biochem Biophys Res Commun.
441:7–12. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
An T, Zhang Y, Huang Y, Zhang R, Yin S,
Guo X, Wang Y, Zou C, Wei B, Lv R, et al: Neuregulin-1 protects
against doxorubicin-induced apoptosis in cardiomyocytes through an
Akt-dependent pathway. Physiol Res. 62:379–385. 2013.PubMed/NCBI
|
|
64
|
Burden S and Yarden Y: Neuregulins and
their receptors: A versatile signaling module in organogenesis and
oncogenesis. Neuron. 18:847–855. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Vaskovsky A, Lupowitz Z, Erlich S and
Pinkas-Kramarski R: ErbB-4 activation promotes neurite outgrowth in
PC12 cells. J Neurochem. 74:979–987. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Di Segni A, Farin K and Pinkas-Kramarski
R: ErbB4 activation inhibits MPP+-induced cell death in
PC12-ErbB4 cells: Involvement of PI3K and Erk signaling. J Mol
Neurosci. 29:257–267. 2006. View Article : Google Scholar
|
|
67
|
McCubrey JA, Steelman LS, Abrams SL, Lee
JT, Chang F, Bertrand FE, Navolanic PM, Terrian DM, Franklin RA,
D'Assoro AB, et al: Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT
pathways in malignant transformation and drug resistance. Adv
Enzyme Regul. 46:249–279. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Junttila MR, Li SP and Westermarck J:
Phosphatase-mediated crosstalk between MAPK signaling pathways in
the regulation of cell survival. FASEB J. 22:954–965. 2008.
View Article : Google Scholar
|
|
69
|
Jo J, Whitcomb DJ, Olsen KM, Kerrigan TL,
Lo SC, Bru-Mercier G, Dickinson B, Scullion S, Sheng M,
Collingridge G and Cho K: Aβ(1-42) inhibition of LTP is mediated by
a signaling pathway involving caspase-3, Akt1 and GSK-3β. Nat
Neurosci. 14:545–547. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Ma T, Du X, Pick JE, Sui G, Brownlee M and
Klann E: Glucagon-like peptide-1 cleavage product GLP-1(9-36) amide
rescues synaptic plasticity and memory deficits in Alzheimer's
disease model mice. J Neurosci. 32:13701–13708. 2012. View Article : Google Scholar : PubMed/NCBI
|
